Get started
Author

Michael S. Magee

Observed names: M.S. Magee, Michael Magee, Michael S Magee, Michael Sullivan Magee, Michael S. Magee, Micheal S Magee
ORCID: 0000-0002-0480-4618
Observed ORCID: 0000-0002-0480-4618
OpenAlex ID: A5031137196
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
2015 · Jonathan F. Goodwin, Vishal Kothari, et al. · Cancer Cell · 180
PDF
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
2018 · Michael S. Magee, Tara S. Abraham, et al. · Cancer Immunology Research · 143
A uroguanylin-GUCY2C endocrine axis regulates feeding in mice
2011 · Michael A. Valentino, Jieru E. Lin, et al. · Journal of Clinical Investigation · 143
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
2016 · Michael S. Magee, Crystal L. Kraft, et al. · OncoImmunology · 87
GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity
2012 · Jieru Egeria Lin, Adam Eugene Snook, et al. · PLoS ONE · 84
PDF
Colorectal cancer immunotherapy.
2013 · Bo Xiang, Adam E Snook, et al. · PubMed · 66
Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
2021 · Kathrin Davari, Tristan Holland, et al. · Journal for ImmunoTherapy of Cancer · 54
PDF
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
2012 · Michael A. Augello, Craig J. Burd, et al. · Journal of Clinical Investigation · 48
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.
2014 · Michael S Magee, Adam E Snook · PubMed · 47
Selective antigen‐specific CD4+T‐cell, but not CD8+T‐ or B‐cell, tolerance corrupts cancer immunotherapy
2014 · Adam E. Snook, Michael S. Magee, et al. · European Journal of Immunology · 40
Bacterial Heat-Stable Enterotoxins: Translation of Pathogenic Peptides into Novel Targeted Diagnostics and Therapeutics
2010 · Jieru E. Lin, Michael Valentino, et al. · Toxins · 38
Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells
2017 · Bo Xiang, Trevor R Baybutt, et al. · The Journal of Immunology · 32
GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
2014 · Glen P. Marszalowicz, Adam E. Snook, et al. · Oncotarget · 28
PDF
Tumor Radiation Therapy Creates Therapeutic Vaccine Responses to the Colorectal Cancer Antigen GUCY2C
2014 · Matthew Witek, Erik S. Blomain, et al. · International Journal of Radiation Oncology*Biology*Physics · 27
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
2011 · Adam E. Snook, Michael S. Magee, et al. · Cancer Immunology Immunotherapy · 20
GUCY2C-targeted cancer immunotherapy: past, present and future
2011 · Adam E. Snook, Michael S. Magee, et al. · Immunologic Research · 19
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
2016 · Casey Ager, Matthew Reilley, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Immunotherapeutic Strategies to Target Prognostic and Predictive Markers of Cancer
2013 · Michael S Magee, Adam E Snook, et al. · Biomarkers in Medicine · 9
Deploying an RNA-Based Gene Writer System and Lipid Nanoparticle (LNP) Delivery to Generate Functional Chimeric Antigen Receptor (CAR) T Cells with in Vitro and In Vivo Anti-Tumor Activity
2023 · Michael S Magee, Alberto De Iaco, et al. · Blood · 5
PDF
A Novel CDX2 Isoform Regulates Alternative Splicing
2014 · Matthew E. Witek, Adam E. Snook, et al. · PLoS ONE · 5
PDF
Knockout of CBLB Greatly Enhances Anti-Tumor Activity of CAR T Cells
2018 · Kathryn Hooper, Kyle Havens, et al. · Blood · 3
Synergistic DNA-adenovirus prime-boost immunization eliminates metastatic colorectal cancer by inducing high avidity effector CD8+ T cells
2014 · Bo Xiang, Peng Li, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Figure S2 from Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
2023 · Michael S. Magee, Tara S. Abraham, et al.
PDF
Figure S10 from Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
2023 · Michael S. Magee, Tara S. Abraham, et al.
Figure S1 from Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
2023 · Michael S. Magee, Tara S. Abraham, et al.
Works count: 50
Citation count: 1,096
H-index: 17
I10-index: 17
Year
Topic
Type